MENU
INBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Inhibrx Biosciences (INBX) Ownership - Who owns Inhibrx Biosciences?

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more

Profile

Industry
N/A
Address
11025 N. Torrey Pines Road
Phone
+1 858 795-4220
Employees
110
Web
https://www.inhibrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.35B
P/E Ratio
0.20
Total Cash
161.66M
Projected Growth
N/A
Total Debt
180.9M
Revenue
1.3M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
11.02
Total Debt/Equity
N/A
Revenue/Share
0.08 USD as % of share price
View a ticker or compare two or three
INBX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company, which engages in researching and developing biotechnology

Industry Biotechnology

Profile
Details
Industry
N/A
Address
11025 N. Torrey Pines Road
Phone
+1 858 795-4220
Employees
110
Web
https://www.inhibrx.com